Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20181970 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo

Study has passed its completion date and status has not been verified in more than two years.